Sato_2014_Clin.Endocrinol.(Oxf)_80_362

Reference

Title : Serum butyrylcholinesterase and the risk of future type 2 diabetes: the Kansai Healthcare Study - Sato_2014_Clin.Endocrinol.(Oxf)_80_362
Author(s) : Sato KK , Hayashi T , Maeda I , Koh H , Harita N , Uehara S , Onishi Y , Oue K , Nakamura Y , Endo G , Kambe H , Fukuda K
Ref : Clinical Endocrinology (Oxf) , 80 :362 , 2014
Abstract : Sato_2014_Clin.Endocrinol.(Oxf)_80_362
ESTHER : Sato_2014_Clin.Endocrinol.(Oxf)_80_362
PubMedSearch : Sato_2014_Clin.Endocrinol.(Oxf)_80_362
PubMedID: 23418907

Related information

Citations formats

Sato KK, Hayashi T, Maeda I, Koh H, Harita N, Uehara S, Onishi Y, Oue K, Nakamura Y, Endo G, Kambe H, Fukuda K (2014)
Serum butyrylcholinesterase and the risk of future type 2 diabetes: the Kansai Healthcare Study
Clinical Endocrinology (Oxf) 80 :362

Sato KK, Hayashi T, Maeda I, Koh H, Harita N, Uehara S, Onishi Y, Oue K, Nakamura Y, Endo G, Kambe H, Fukuda K (2014)
Clinical Endocrinology (Oxf) 80 :362